BIOPHARMA DEVELOPMENT AI BY BCG X
Live / Applied — First extension granted (statement of use) (as of 16 Mar 2026)
What this means for you
Not registered yet, but its 23 Dec 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98919023
- Mark type
- Design + words
- Filed
- 23 Dec 2024
- Published for opposition
- 22 Jul 2025
- Attorney of record
- Michael Geller
Goods and services
- Class 035 — Advertising and business services: Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; consulting services regarding cost containment in the field of clinical trials
- Class 042 — Scientific and technological services: Providing temporary use of online non-downloadable software for business process management; providing temporary use of online non-downloadable generative AI software to assist businesses with clinical trial design, execution, evaluation, and drafting or related reports; providing temporary use of online non-downloadable software to automate document writing for the design, execution, and evaluation of clinical trials; providing temporary use of online non-downloadable software for business management and optimization purposes using technical data, data modelling, AI modelling, and algorithmic processes; providing technical consulting services to businesses in the field of clinical trial optimization, optimizing resource utilization, and improving success rates; providing scientific and technological consulting services for others with regard to the design, planning, management, and optimization of scientific research and clinical trials; consulting services for others in the field of design, planning, and implementation project management of clinical trials
Owner
- The Boston Consulting Group, Inc., Boston, MA, US
- The Boston Consulting Group, Inc., Boston, MA, US
Prior registrations
Prosecution history
- 17 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Mar 2026 — SOU EXTENSION 1 GRANTED
- 16 Mar 2026 — SOU EXTENSION 1 FILED
- 16 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 20 Jan 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 20 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 20 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 16 Sept 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 22 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 22 Jul 2025 — PUBLISHED FOR OPPOSITION
- 16 Jul 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Jun 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Jun 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 17 Jun 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE